Clinical Trial Update: Pulmonary Hypertension in Lymphangioleiomyomatosis

View source ↗

Summary

A clinical trial evaluating pulmonary hypertension in lymphangioleiomyomatosis has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Lymphangioleiomyomatosis
• Pulmonary Hypertension

Snippet

Sponsor: Groupe d'Etudes et de Recherche sur les Maladies Orphelines Pulmonaires | Conditions: Lymphangioleiomyomatosis, Pulmonary Hypertension | Status: COMPLETED